|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/22/2024 |
$15.28 |
$15.35 |
$14.93 |
$15.10 |
1.02M | 04/23/2024 |
$15.20 |
$15.23 |
$14.73 |
$14.73 |
992.50K | 04/24/2024 |
$14.80 |
$15.19 |
$14.73 |
$15.12 |
942.10K | 04/25/2024 |
$14.87 |
$15.07 |
$14.59 |
$14.68 |
926.30K | 04/26/2024 |
$14.84 |
$15.06 |
$14.71 |
$14.89 |
772.20K |
|
Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s main US commercial product is FIRDAPSE® (amifampridine) Tablets 10 mg approved for the treatment of Lambert-Eaton myasthenic syndrome for adults and for children ages six and up. Co. has the US rights to FYCOMPA®(perampanel) CIII, a prescription medication used alone or with other medicines to treat focal onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat generalized tonic-clonic seizures in people with epilepsy aged 12 and older. | |
|
Catalyst Pharmaceuticals (CPRX) has the following price history information. Looking back at CPRX historical stock prices for the last five trading days, on April 22, 2024, CPRX opened at $15.28, traded as high as $15.35 and as low as $14.93, and closed at $15.10. Trading volume was a total of 1.02M shares. On April 23, 2024, CPRX opened at $15.20, traded as high as $15.23 and as low as $14.73, and closed at $14.73. Trading volume was a total of 992.50K shares. On April 24, 2024, CPRX opened at $14.80, traded as high as $15.19 and as low as $14.73, and closed at $15.12. Trading volume was a total of 942.10K shares. On April 25, 2024, CPRX opened at $14.87, traded as high as $15.07 and as low as $14.59, and closed at $14.68. Trading volume was a total of 926.30K shares. On April 26, 2024, CPRX opened at $14.84, traded as high as $15.06 and as low as $14.71, and closed at $14.89. Trading volume was a total of 772.20K shares.
CPRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Catalyst Pharmaceuticals shares, starting with a $10,000 purchase of CPRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$2.01 |
|
End price/share: |
$14.89 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
640.80% |
|
Average Annual Total Return: |
22.17% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$74,070.58 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/22/2024 | $15.10 | 04/23/2024 | $14.73 | 04/24/2024 | $15.12 | 04/25/2024 | $14.68 | 04/26/2024 | $14.89 |
|
|